bivalent bnt162b2
Trade name: Comirnaty
Vaccineexperimental
Clinical trial activity
15 trials · 19 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
7
Phase 3
6
Phase 4
1
Earliest trial started Nov 22, 2021 (NCT05668065)
Timeline
Indications
Approved for
Mechanism of action
- Spike glycoproteinImmunity, active
Spike glycoprotein immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05925127 | Phase 2/Phase 3 (Phase 3) | Oct 16, 2023 | Novavax |
| NCT05930730 | Phase 2 | Oct 9, 2023 | Chulalongkorn University, HIV-NAT Thai Red Cross AIDS Research Center |
| NCT05911087 | Phase 2/Phase 3 (Phase 3) | Jun 20, 2023 | Government of Cambodia, Stemirna Therapeutics |
| NCT05886777 | Phase 2 | Jun 5, 2023 | Pfizer |
| NCT05886790 | N/A | May 30, 2023 | People's Liberation Army of China, Xiamen University |
| NCT05543356 | Phase 3 | Feb 28, 2023 | Coalition for Epidemic Preparedness Innovations, Murdoch University, The Peter Doherty Institute |
| NCT05630352 | Phase 1 | Jan 19, 2023 | Biontech, Pfizer |
| NCT05637671 | Phase 3 | Dec 31, 2022 | Cairo University |
| NCT05541861 | Phase 1 | Nov 8, 2022 | Biontech, Pfizer |
| NCT05596734 | Phase 1 | Oct 28, 2022 | Biontech, Pfizer |
| NCT05970887 | Phase 4 | Oct 12, 2022 | Catholic Kwandong University, Korea University |
| NCT05547243 | N/A | Sep 26, 2022 | AIM Therapeutics Inc., Bengbu Medical College, Government of China |
| NCT05543616 | Phase 3 | Sep 23, 2022 | Biontech, Pfizer |
| NCT05472038 | Phase 2 | Jul 26, 2022 | Biontech, Pfizer |
| NCT05668065 | Phase 3 | Nov 22, 2021 | Institut Pasteur |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (19)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 6 | 1 | 3 | 2022 |
| Biontech | For profit | 5 | 5 | 3 | 2022 |
| AIM Therapeutics Inc. | For profit | 1 | 0 | 1 | 2022 |
| Bengbu Medical College | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Catholic Kwandong University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Chulalongkorn University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Coalition for Epidemic Preparedness Innovations | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Government of Cambodia | Government | 1 | 0 | 1 | 2023 |
| Government of China | Government | 1 | 1 | 1 | 2022 |
| HIV-NAT Thai Red Cross AIDS Research Center | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Institut Pasteur | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Murdoch University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Novavax | For profit | 1 | 1 | 1 | 2023 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2023 |
| Stemirna Therapeutics | For profit | 1 | 1 | 1 | 2023 |
| The Peter Doherty Institute | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Xiamen University | Academic/Hospital | 1 | 1 | 1 | 2023 |
19 organizations
Page 1 / 1